Real-time enrollment status for this primary mitochondrial disease clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 5:09 AM UTC
| NCT Number | NCT05650229 |
| Recruiting Status | Recruiting |
| Condition | Primary Mitochondrial Disease |
| Phase | Clinical Trial |
| Target Enrollment | 180 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Abliva AB |
| Last Updated on CT.gov | April 15, 2026 (2 days ago) |
As of April 17, 2026: Clinical trial NCT05650229 is currently recruiting participants. This clinical trial study for primary mitochondrial disease is actively seeking new participants at 2 locations across the United States. The study is sponsored by Abliva AB. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05650229 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05650229 was last updated 2 days ago (April 15, 2026). HelloStudys verifies this status automatically.